BLCO — BAUSCH LOMB CORP

Health Care

Sign in to save5 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying BLCO?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence
95
Institutional Conviction
Strong accumulation · 5 buying vs 0 selling last quarter
77
Macro Tailwind
Macro conditions are mixed for this sector
53
Why? — Evidence & Confidence ▾

Of 5 tracked investors who changed their BLCO position last quarter, 5 bought and 0 sold (100% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 53/100 in a Expansion regime).

Supporting evidence
  • +5 tracked investors added or increased positions last quarter (Daniel Loeb, Izzy Englander, Carl Icahn, …)
  • +5 tracked investors reported holding BLCO at their latest filing
Contradicting evidence — always shown
  • 13F data is disclosed up to 45 days after quarter end — positions may have changed since
Know the limits
  • · 13F disclosure lag (up to 45 days)
  • · Tracked investors are a sample, not the whole market
  • · Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/19/2026.

About BAUSCH LOMB CORP (BLCO)

BAUSCH LOMB CORP (BLCO) appears in the most recent 13F filings of 5 tracked institutional investors. BAUSCH LOMB CORP is classified in the Health Care sector. The largest disclosed position is held by Carl Icahn (Icahn Capital), valued at $68M. Across recent filings, tracked investors recorded 13 new positions, 6 increased, 3 reduced, and 6 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in BLCO

68
/100
Institutional Accumulation
Added / Increased19
Reduced3
Exited6
BearishBullish
Crowded Trade Score™

How many top investors track BLCO

33
/100
Emerging Interest
5investors

A small number of top investors own this.

UndiscoveredCrowded
151015+

BLCO Ownership Composition

How BAUSCH LOMB CORP is held across tracked investor types, based on reported 13F positions.

Dominant Type
Activist
43% of tracked value
Institutions
5
tracked investors
Total Reported
$139.3M
combined 13F value
Types3
  • Activist42.6%
  • Value & Distressed40.9%
  • Multi-Strategy / Quant16.5%
Activist(2)
42.6%
Value & Distressed(1)
40.9%
Multi-Strategy / Quant(2)
16.5%

Tracked investors currently reporting BLCO

2 tracked investors have since exited this position — listed separately below.

  • Carl IcahnJun 30, 2026
    Icahn Capital
    Shares
    3.5M
    Value
    $58M
    % Portfolio
    0.70%
  • Howard MarksJun 30, 2026
    Oaktree Capital Management
    Shares
    3.4M
    Value
    $57M
    % Portfolio
    0.79%
  • Ken GriffinJun 30, 2026
    Citadel Advisors
    Shares
    1M
    Value
    $17M
    % Portfolio
    0.00%
  • Izzy EnglanderJun 30, 2026
    Millennium Management
    Shares
    357.1K
    Value
    $5.9M
    % Portfolio
    0.00%
  • Daniel LoebJun 30, 2026
    Third Point LLC
    Shares
    85K
    Value
    $1.4M
    % Portfolio
    0.03%

Previously held BLCO

These investors reported BLCO in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.

InvestorFirmLast reported sharesValue thenLast held
Steve CohenPoint72 Asset Management217.6K$3.2MMar 31, 2025
Paul Tudor JonesTudor Investment Corp149.3K$2.2MSep 30, 2025

Recent activity

Frequently asked questions

How many institutional investors hold BLCO?
5 tracked institutional investors disclosed a position in BLCO (BAUSCH LOMB CORP) in their most recent 13F filing.
Who is the largest institutional holder of BLCO?
Carl Icahn, Icahn Capital, holds the largest disclosed position in BLCO, valued at $68M.
Did institutional ownership of BLCO increase or decrease?
Across recent 13F filings, tracked investors recorded 13 new positions, 6 increased, 3 reduced, and 6 fully exited BLCO.
What sector is BLCO in?
BAUSCH LOMB CORP is classified in the Health Care GICS sector.
Where does this BLCO ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.
BLCO (BAUSCH LOMB CORP) — Institutional Holders & 13F — InvestorLens